Return to homepagePandemic Pact

Emotional impact of separating women giving birth during COVID-19 lockdown

  • Funded by Fondation pour la Recherche Médicale
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $196,029.6

  • Funder

    Fondation pour la Recherche Médicale

  • Principal Investigator

    Pr. Karine Lacombe, Pierre Tiberghien

  • Research Location

    France

  • Lead Research Institution

    AP-HP St Antoine, Sorbonne Université

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Clinical trials for disease management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    WomenPregnant women

  • Occupations of Interest

    Unspecified

Abstract

This trial will test the effectiveness of injecting plasma from patients recovered from Covid-19 to hospitalized but unventilated patients. The plasma of recovered patients contains antibodies developed by their body and directed against the virus involved, SARS-Cov-2. Transfused to patients, this plasma could give them immunity and help them fight against Covid-19. The plasma will be collected by the French Blood Establishment (EFS) from former convalescent patients. This therapeutic approach could on the one hand prevent hospitalized patients with mild to moderate expression of Covid-19 from being ventilated in currently saturated emergency care units, and on the other hand reduce overall mortality due to Covid-19. The FRM is also involved in the fundamental evaluation of the results of the CORIPLASM study through ancillary studies (appendices), as well as in an extension of the protocol in intensive care patients (CORIPLASMIC study).